These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29462644)

  • 21. [Splenic blood circulation in liver cirrhosis with portal hypertension syndrome].
    Bulanov KI
    Klin Khir; 1998; (8):29-31. PubMed ID: 9866318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis.
    Møller S
    Dan Med Bull; 1998 Feb; 45(1):1-14. PubMed ID: 9504263
    [No Abstract]   [Full Text] [Related]  

  • 23. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Portal hemodynamic disturbance in the evolution of hepatic cirrhosis. Evaluation by the splenoportographic method].
    VARELA FUENTES B; ARCOS PEREZ M; PAVLOTZKY M; PEREZ FERNANDEZ M; PARODI A
    Rev Med Chil; 1961 Oct; 89():738-46. PubMed ID: 13924826
    [No Abstract]   [Full Text] [Related]  

  • 25. [STUDY OF SOME PHARMACEUTICAL EFFECTS ON SYSTEMIC AND SPLANCHNIC HEMODYNAMICS. II. ACTION OF OCTAPRESSIN IN NORMAL AND CIRRHOTIC HUMANS].
    FERUGLIO FS; CHIANDUSSI L; GRECO F; CESANO L; INDOVINA D; MURATORI F
    Minerva Med; 1963 Oct; 54():3114-8. PubMed ID: 14099156
    [No Abstract]   [Full Text] [Related]  

  • 26. Complications of cirrhosis. A 50 years flashback.
    Møller S; Bendtsen F
    Scand J Gastroenterol; 2015 Jun; 50(6):763-80. PubMed ID: 25881709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension.
    Seijo S; Reverter E; Miquel R; Berzigotti A; Abraldes JG; Bosch J; García-Pagán JC
    Dig Liver Dis; 2012 Oct; 44(10):855-60. PubMed ID: 22721839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of portal hypertension in HCV-related cirrhosis. Putative role of assessment of portal pressure gradient in Peginterferon-treated patients.
    Ratti L; Pozzi M; Bosch J
    Dig Liver Dis; 2005 Nov; 37(11):886-93. PubMed ID: 16172033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers of immunity and bacterial translocation in cirrhosis.
    Mortensen C
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of distal splenocaval shunt on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension].
    Cai JX
    Zhonghua Wai Ke Za Zhi; 1991 Jul; 29(7):426-8, 462. PubMed ID: 1813226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Echographic and hemodynamic indicators in liver cirrhosis with portal hypertension].
    Rikhsieva LE; Akhmedzhanova ShSh; Miasnik BN
    Sov Med; 1989; (2):13-5. PubMed ID: 2658117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
    Hernández-Guerra M; García-Pagán JC; Turnes J; Bellot P; Deulofeu R; Abraldes JG; Bosch J
    Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.
    Møller S; Henriksen JH; Bendtsen F
    World J Gastroenterol; 2014 Nov; 20(42):15499-517. PubMed ID: 25400435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of etiological treatment on prognosis.
    Su CW; Yang YY; Lin HC
    Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in portal hemodynamics in cirrhosis and idiopathic portal hypertension.
    Ohnishi K; Chin N; Tanaka H; Iida S; Sato S; Terabayashi H; Nomura F
    Am J Gastroenterol; 1989 Apr; 84(4):409-12. PubMed ID: 2929562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: a case-control study.
    Schepis F; Vukotic R; Berzigotti A; Carrión JA; Forns X; Abraldes JG; García-Valdecasas JC; Navasa M; García-Pagán JC; Bosch J
    Liver Transpl; 2013 Apr; 19(4):450-6. PubMed ID: 23408436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemodynamic interrelations in portal hypertension caused by hepatic cirrhosis].
    Garcia Civera R; Benages Martínez A; Lopez Merino F; Garcia-Conde Gomez FJ
    Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):19-34. PubMed ID: 5069488
    [No Abstract]   [Full Text] [Related]  

  • 40. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
    Orrego Matte H
    Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.